Clinical trials
Recruiting Lung Diseases, Interstitial trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
54 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2003 | 1 |
| 2005 | 1 |
| 2011 | 1 |
| 2014 | 1 |
| 2017 | 1 |
| 2018 | 2 |
| 2020 | 1 |
| 2021 | 4 |
| 2022 | 2 |
| 2023 | 7 |
| 2024 | 9 |
| 2025 | 7 |
| 2026 | 17 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 54 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| GlaxoSmithKline | 4 |
| Bastiaan Driehuys | 3 |
| Mayo Clinic | 3 |
| Boehringer Ingelheim | 2 |
| Children's Hospital Medical Center, Cincinnati | 2 |
| Insmed Incorporated | 2 |
| Liquidia Technologies, Inc. | 2 |
| Pulmovant, Inc. | 2 |
| United Therapeutics | 2 |
| University of Colorado, Denver | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Lung Diseases, Interstitial | 54 |
| Hypertension, Pulmonary | 14 |
| Idiopathic Pulmonary Fibrosis | 9 |
| Pulmonary Fibrosis | 9 |
| Lung Diseases | 7 |
| Scleroderma, Diffuse | 6 |
| Scleroderma, Systemic | 6 |
| Connective Tissue Diseases | 5 |
| Fibrosis | 5 |
| Cardiovascular Diseases | 3 |
Trials
Showing 1 to 25 of 54. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.